help button home button
AJRCCM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH

Published ahead of print on October 6, 2005, doi:10.1164/rccm.200409-1298OC

Am. J. Respir. Crit. Care Med., Volume 173, Number 1, January 2006, 105-111

A more recent version of this article appeared on January 1, 2006
This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
200409-1298OCv1
173/1/105    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ryu, J. H
Right arrow Articles by Fanburg, B. L
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ryu, J. H
Right arrow Articles by Fanburg, B. L

Submitted on September 29, 2004
Accepted on September 30, 2005

The NHLBI Lymphangioleiomyomatosis Registry: Characteristics of 230 Patients at Enrollment

Jay H Ryu1*, Joel Moss2, Gerald J Beck3, Jar-Chi Lee3, Kevin K Brown4, Jeffrey T Chapman5, Geraldine A Finlay6, Eric J Olson1, Stephen J Ruoss7, Janet R Maurer8, Thomas A Raffin7, Hannah H Peavy9, Kevin McCarthy3, Angelo Taveira-DaSilva2, Francis X McCormack10, Nilo A Avila11, Rosamma M DeCastro2, Susan S Jacobs7, Mario Stylianou12, and Barry L Fanburg6

1 Division of Pulmonary and Critical Care Medicine, Mayo Clinic, Rochester, MN, United States, 2 Pulmonary-Critical Care Medicine Branch, National Heart, Lung, and Blood Institute, Bethesda, MD, USA, 3 Department of Quantitative Health Sciences, Cleveland Clinic Foundation, Cleveland, OH, USA, 4 National Jewish Medical and Research Center, Denver, CO, USA, 5 Department of Critical Care, Allergy and Pulmonary Medicine, Cleveland Clinic Foundation, Cleveland, OH, USA, 6 Pulmonary and Critical Care Division, New England Medical Center, Boston, MA, USA, 7 Division of Pulmonary and Critical Care Medicine, Stanford University Medical Center, Standford, CA, USA, 8 CIGNA HealthCare, Bloomfield, CT, USA, 9 Division of Lung Diseases, National Institutes of Health, National Heart, Lung, and Blood Institute Project Office, Bethesda, MD, USA, 10 Division of Pulmonary and Critical Care Medicine, University of Cincinnati, Cincinnati, OH, USA, 11 Department of Diagnostic Radiology, National Institutes of Health, Warren G. Magnuson Clinical Center, Bethesda, MD, USA, 12 Biostatistics Research Branch, Division of Epidemiology and Clinical Applications, National Heart, Lung, and Blood Institute, Bethesda, MD, USA

* To whom correspondence should be addressed. E-mail: ryu.jay{at}mayo.edu.

Rationale: Pulmonary lymphangioleiomyomatosis is a progressive cystic lung disease that is associated with infiltration of atypical smooth muscle-like cells. Previous descriptions of clinical characteristics of subjects with lymphangioleiomyomatosis have been based on a limited number of patients. Objectives: To describe the clinical characteristics of subjects with pulmonary lymphangioleiomyomatosis, both sporadic and tuberous sclerosis-related forms. Methods: Over a three-year period from 1998 to 2001, 243 subjects with pulmonary lymphangioleiomyomatosis were enrolled into a national Registry; 13 subjects who had already undergone lung transplantation were excluded for the purposes of this report. Measurements and Main Results: All 230 subjects were women, aged 18 to 76 years (mean ± SE, 44.5 ± 0.65 years). The average age at onset of symptoms was 38.9 ± 0.73 years and at diagnosis was 41.0 ± 0.65 years. Tuberous sclerosis complex was present in 14.8% of subjects. Pulmonary manifestations, most commonly spontaneous pneumothorax, were the primary events leading to the diagnosis in 86.5% of cases. Nearly 55% of the subjects were being treated with a progesterone derivative. An obstructive pattern on pulmonary function testing was observed in 57.3% of the subjects, while 33.9% had normal spirometric results. Women with tuberous sclerosis-related lymphangioleiomyomatosis were younger and had less impaired lung function compared to those with the sporadic form. Conclusions: The age range of women afflicted with pulmonary lymphangioleiomyomatosis is broader than previously appreciated and the degree of pulmonary function can be quite variable, with one-third of subjects having normal spirometry at enrollment into this Registry.


Key words: lymphangioleiomyomatosis, tuberous sclerosis, registry.




This article has been cited by other articles:


Home page
ChestHome page
C. D. Burger and F. X. McCormack
Variability in the Prevalence of Acute Bronchoresponsiveness in Different Populations of Patients With Lymphangioleiomyomatosis
Chest, July 1, 2008; 134(1): 217 - 218.
[Full Text] [PDF]


Home page
ThoraxHome page
J W Wilson, R M du Bois, and T E King Jr
Challenges in pulmonary fibrosis: 8 {middle dot} The need for an international registry for idiopathic pulmonary fibrosis
Thorax, March 1, 2008; 63(3): 285 - 287.
[Abstract] [Full Text] [PDF]


Home page
ChestHome page
F. X. McCormack
Lymphangioleiomyomatosis: A Clinical Update
Chest, February 1, 2008; 133(2): 507 - 516.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
C. D. Burger
S-LAM in Men: Is Pulmonary Function Different from That Seen in Women?
Am. J. Respir. Crit. Care Med., February 1, 2008; 177(3): 356 - 356.
[Full Text] [PDF]


Home page
ChestHome page
S. Harari, R. Cassandro, J. Chiodini, A. M. Taveira-DaSilva, and J. Moss
Effect of a Gonadotrophin-Releasing Hormone Analogue on Lung Function in Lymphangioleiomyomatosis
Chest, February 1, 2008; 133(2): 448 - 454.
[Abstract] [Full Text] [PDF]


Home page
NEJMHome page
J. J. Bissler, F. X. McCormack, L. R. Young, J. M. Elwing, G. Chuck, J. M. Leonard, V. J. Schmithorst, T. Laor, A. S. Brody, J. Bean, et al.
Sirolimus for Angiomyolipoma in Tuberous Sclerosis Complex or Lymphangioleiomyomatosis
N. Engl. J. Med., January 10, 2008; 358(2): 140 - 151.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
G. Pacheco-Rodriguez, W. K. Steagall, D. M. Crooks, L. A. Stevens, H. Hashimoto, S. Li, J.-a. Wang, T. N. Darling, and J. Moss
TSC2 Loss in Lymphangioleiomyomatosis Cells Correlated with Expression of CD44v6, a Molecular Determinant of Metastasis
Cancer Res., November 1, 2007; 67(21): 10573 - 10581.
[Abstract] [Full Text] [PDF]


Home page
ChestHome page
A. M. Taveira-DaSilva, O. M. Hathaway, V. Sachdev, Y. Shizukuda, C. W. Birdsall, and J. Moss
Pulmonary Artery Pressure in Lymphangioleiomyomatosis: An Echocardiographic Study
Chest, November 1, 2007; 132(5): 1573 - 1578.
[Abstract] [Full Text] [PDF]


Home page
J. Med. Genet.Home page
Y. Gunji, T. Akiyoshi, T. Sato, M. Kurihara, S. Tominaga, K. Takahashi, and K. Seyama
Mutations of the Birt Hogg Dube gene in patients with multiple lung cysts and recurrent pneumothorax
J. Med. Genet., September 1, 2007; 44(9): 588 - 593.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
W. K. Steagall, C. G. Glasgow, O. M. Hathaway, N. A. Avila, A. M. Taveira-DaSilva, A. Rabel, M. P. Stylianou, J.-P. Lin, X. Chen, and J. Moss
Genetic and morphologic determinants of pneumothorax in lymphangioleiomyomatosis
Am J Physiol Lung Cell Mol Physiol, September 1, 2007; 293(3): L800 - L808.
[Abstract] [Full Text] [PDF]


Home page
ChestHome page
D. S. Ayo, G. L. Aughenbaugh, E. S. Yi, J. L. Hand, and J. H. Ryu
Cystic Lung Disease in Birt-Hogg-Dube Syndrome
Chest, August 1, 2007; 132(2): 679 - 684.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
M. Schiavina, V. Di Scioscio, P. Contini, A. Cavazza, A. Fabiani, M. Barberis, A. Bini, A. Altimari, R. M. T. Cooke, W. F. Grigioni, et al.
Pulmonary Lymphangioleiomyomatosis in a Karyotypically Normal Man without Tuberous Sclerosis Complex
Am. J. Respir. Crit. Care Med., July 1, 2007; 176(1): 96 - 98.
[Abstract] [Full Text] [PDF]


Home page
CMAJHome page
E. Weir and M. Cohen
A 48-year-old woman with lymphangioleiomyomatosis
Can. Med. Assoc. J., April 24, 2007; 176(9): 1271 - 1272.
[Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
A. U. Wells and C. M. Hogaboam
Update in Diffuse Parenchymal Lung Disease 2006
Am. J. Respir. Crit. Care Med., April 1, 2007; 175(7): 655 - 660.
[Full Text] [PDF]


Home page
Am. J. Respir. Cell Mol. Bio.Home page
S. C. Juvet, F. X. McCormack, D. J. Kwiatkowski, and G. P. Downey
Molecular Pathogenesis of Lymphangioleiomyomatosis: Lessons Learned from Orphans
Am. J. Respir. Cell Mol. Biol., April 1, 2007; 36(4): 398 - 408.
[Abstract] [Full Text] [PDF]


Home page
Eur Respir JHome page
T. B. L. Ho, J. H. Hull, and N. C. Hughes
An 86-year-old female with lymphangioleiomyomatosis.
Eur. Respir. J., November 1, 2006; 28(5): 1065 - 1064.
[Full Text] [PDF]


Home page
NEJMHome page
P. B. Crino, K. L. Nathanson, and E. P. Henske
The Tuberous Sclerosis Complex.
N. Engl. J. Med., September 28, 2006; 355(13): 1345 - 1356.
[Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
F. J. Martinez and M. P. Keane
Update in diffuse parenchymal lung diseases 2005.
Am. J. Respir. Crit. Care Med., May 15, 2006; 173(10): 1066 - 1071.
[Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
A. E. Tattersfield and M. K. Glassberg
Lymphangioleiomyomatosis: A National Registry for a Rare Disease
Am. J. Respir. Crit. Care Med., January 1, 2006; 173(1): 2 - 4.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Proc. Am. Thorac. Soc. Am. J. Respir. Cell Mol. Biol.
Copyright © 2005 American Thoracic Society